Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Global Longlife Hospital and Research Ltd (NSE: GLHRL), ISIN INE0J2K01014 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
GLHRL last traded at ₹14.78 (+1.72%), with a 52-week range of ₹9.00 to ₹26.73 (as of 23 Sep 2026).
Shareholding as of Dec 2025: promoters 35.44%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 37/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.